Genstar Capital completes acquisition of PRA

San Francisco-based private equity firm Genstar Capital LLC has completed its $797 milion acquisition of PRA International, a global clinical research organization based in North Carolina, the company announced today.

Shareholders approved the acquisition Wednesday and will receive $30.50 per share of common stock in cash. PRA stock will be delisted from Nasdaq at the close of the  markets.

businessBusiness & Real Estate

If you find our journalism valuable and relevant, please consider joining our Examiner membership program.
Find out more at www.sfexaminer.com/join/

Just Posted

Pandemic exacerbates food insecurity for San Franciscans in need

Mayor Breed proposes $45.7 million for meal programs under two-year budget

Doing No Harm: Ahimsa Sumchai

Doctor tracks health of Bayview residents affected by toxins from former shipyard

Francis Ford Coppola to turn part of landmark Columbus Tower into boutique hotel

Famed ‘Godfather’ director speaks about North Beach plans at local hearing

‘Major surge’ in COVID-19 cases prompts plans for Presidio medical site

SF diagnosing an average of 98 new coronavirus cases daily

Most Read